According to our (Global Info Research) latest study, the global Mirogabalin Besilate Tablets market size was valued at US$ 504 million in 2025 and is forecast to a readjusted size of US$ 1200 million by 2032 with a CAGR of 11.7% during review period.
Mirogabalin Besilate Tablets Is A Novel, Selective, And Centrally Acting Analgesic Agent, Which Mainly Acts On The Voltage-Gated Calcium Channels In The Central Nervous System. It Can Effectively Reduce The Release Of Pain-Related Neurotransmitters, Improve Abnormal Nerve Signal Transmission, And Is Clinically Mainly Indicated For The Treatment Of Peripheral Neuropathic Pain In Adult Patients. With High Analgesic Efficiency And Good Tolerability, This Drug Has Become An Important Therapeutic Option For Chronic Neuralgia Diseases.n 2025, global Mirogabalin Besilate Tablets production reached approximately 4,000,000 bottles.
Mirogabalin Besylate Tablets are a novel central analgesic agent, primarily indicated for the treatment of diabetic peripheral neuropathic pain in adults. With a unique pharmacological mechanism of action, it fills the gap in the relevant clinical treatment field.
Classified as a third-generation calcium channel modulator, this drug boasts steady analgesic efficacy, favorable tolerability and a low incidence of adverse reactions compared with conventional analgesics. It is better suited to the long-term treatment needs of patients with chronic neuralgia and has gained wide recognition in clinical practice.
From the perspective of market demand, the high prevalence of underlying diseases has resulted in a sustained patient population with related painful conditions. The growing clinical demand for safe and innovative analgesic drugs has laid a solid foundation for the market development of this product.
At present, the market is dominated by the original branded drug, while multiple pharmaceutical enterprises have launched the research and development of generic versions, forming a competitive landscape led by the original drug with generics in active pursuit.
Supported by medical insurance policies, improved clinical accessibility and the gradual launch of generic drugs, its market coverage will be further expanded. Meanwhile, the product will face intensified market competition. Its future market development will focus on the enhancement of clinical value, optimization of channel distribution and differentiated product competition
This report is a detailed and comprehensive analysis for global Mirogabalin Besilate Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mirogabalin Besilate Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirogabalin Besilate Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirogabalin Besilate Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirogabalin Besilate Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mirogabalin Besilate Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mirogabalin Besilate Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Daiichi Sankyo, Jiangsu Lianhuan Pharmaceutical, Chongqing Huabang Pharmaceutical, Shandong Jingwei Pharmaceutical, Hainan Herui Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mirogabalin Besilate Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2.5mg
5mg
Market segment by Production Technology
Original
Generic
Market segment by Combination Therapy
Mirogabalin Besylate + Mecobalamin
Mirogabalin Besylate + Duloxetine
Market segment by Application
Diabetic Peripheral Neuropathic Pain
Postherpetic Neuralgia
Fibromyalgia Syndrome
Others
Major players covered
Daiichi Sankyo
Jiangsu Lianhuan Pharmaceutical
Chongqing Huabang Pharmaceutical
Shandong Jingwei Pharmaceutical
Hainan Herui Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mirogabalin Besilate Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mirogabalin Besilate Tablets, with price, sales quantity, revenue, and global market share of Mirogabalin Besilate Tablets from 2021 to 2026.
Chapter 3, the Mirogabalin Besilate Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mirogabalin Besilate Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mirogabalin Besilate Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mirogabalin Besilate Tablets.
Chapter 14 and 15, to describe Mirogabalin Besilate Tablets sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Mirogabalin Besilate Tablets. Industry analysis & Market Report on Mirogabalin Besilate Tablets is a syndicated market report, published as Global Mirogabalin Besilate Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Mirogabalin Besilate Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.